The self-reported use of marijuana by teenagers continues to decline nationally, according to federal data reported by the United States Substance Abuse and Mental Health Services Administration (SAMHSA).
The use of cannabis during adolescence is not associated with structural brain differences in adulthood, according to longitudinal data published in the journal Drug and Alcohol Dependence. Researchers concluded, “[T]he patterns of cannabis use typically seen in community-dwelling adolescents does not appear to have lasting effects on brain structure.”
Federal officials have approved plans for the University of Mississippi to grow 2,000 kilograms (4,409 pounds) of cannabis to provide to investigators for clinical trial research.
The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. Commenting on the study’s findings, NORML Deputy Director Paul Armentano said, “These conclusions add to the growing body of evidence that cannabis and its constituents represent an exit away from the use or abuse of other controlled substances rather than a supposed ‘gateway.'”
NORML has submitted written comments to the US Food and Drug Administration ahead of the agency’s scheduled hearing on the regulation CBD-infused products. The agency will be taking in person public testimony on Friday, May 31, with regard to the “manufacturing, product quality, marketing, labeling, and sale” of CBD-infused retail products.
The passage of statewide adult use marijuana laws is associated with an immediate uptick in housing prices, according to an assessment published by the online service Clever Real Estate.